Small Cap Annovis Bio Inc. (NYSE: ANVS) stock is trading higher on Monday, with a session volume of 12.29 million compared to the average volume of 615.12 thousand as per data from Benzinga Pro. A ...

Disclosure: Our goal is to feature products and services that we think you'll find interesting and useful. If you purchase them, Entrepreneur may get a small share of the revenue from the sale from ...

As scientific disinformation skyrockets, the Biotechnology Innovation Organization (BIO)—the world’s largest biotech trade association—is aiming to set the record straight on vaccines, rolling out a ...

Shares of Gossamer Bio (NASDAQ:GOSS) traded higher on Wednesday after UBS upgraded the California-based biotech to Buy from Neutral, citing an “underappreciated” late-stage data catalyst related to ...

The July data breach at U.S. insurance giant Allianz Life allowed hackers to steal the personal information of 1.1 million customers, according to data breach notification site Have I Been Pwned.

Biogen (NASDAQ:BIIB)/Eisai (OTCPK:ESALF) and Eli Lilly (NYSE:LLY) on Wednesday announced data from long-term extension studies for their respective FDA-approved Alzheimer’s drugs, lecanemab-irmb ...

Doug Wintemute is a staff writer for Forbes Advisor. After completing his master’s in English at York University, he began his writing career in the higher education space. Over the past decade, Doug ...

This issue is preventing our website from loading properly. Please review the following troubleshooting tips or contact us at [email protected]. By submitting your ...

A California-startup focused on genetically editing human embryos — a step toward creating so-called designer babies — is raising money as many of Silicon Valley’s ultra-rich turn their attention to ...

Living 150 years could not just be possible – it could soon be inevitable, according to human biologist and biohacker Gary Brecka. "If you're alive in five years, I believe it will be your choice ...

A priceless treasure trove of biodata gathered from generations of Americans by Harvard University researchers may soon be lost due to additional funding cuts by the Trump administration, a leading ...

Shanghai-based D3 Bio (Wuxi) Co. Ltd. showed positive results for its lead candidate, next-generation KRAS G12C inhibitor, D3S-001, also known as elisrasib, in patients with KRAS G12C mutation cancers ...